Endocrine, Metabolic, Inflammatory Biomarkers to Identify Highgrade Dysplasia/invasive Carcinoma in Patients with IPMN of the Pancreas
RecruitingOBSERVATIONAL
Enrollment
586
Participants
Timeline
Start Date
July 13, 2020
Primary Completion Date
January 31, 2025
Study Completion Date
March 31, 2025
Conditions
Intraductal Papillary Mucinous Neoplasm of PancreasPancreatic Cyst
Trial Locations (1)
20132
RECRUITING
San Raffaele Hospital, Milan
All Listed Sponsors
lead
IRCCS San Raffaele
OTHER
NCT06706700 - Endocrine, Metabolic, Inflammatory Biomarkers to Identify Highgrade Dysplasia/invasive Carcinoma in Patients with IPMN of the Pancreas | Biotech Hunter | Biotech Hunter